Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine delivery method after total knee arthroplasty
ACTRN12619000221156Phase 4Recruiting
- Sponsor
- Counties Manukau District Health Board
- Start
- May 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain, sponsored by Counties Manukau District Health Board. Primary endpoint: Total oral morphine consumption over 48 hours. Started May 2019; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ACTRN12619000221156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000221156.